This week's edition of Life Sciences weekly highlights includes news and a Law 360 analysis of the CAT’s handing down of two further appeal decisions in Allergan PLC v CMA upholding the CMA’s findings in the first instance but permitting the ‘due process’ appeals because it felt the CMA did not fully present its case under cross-examination of key witnesses in regards to the unlawful agreements it entered to keep 10 mg hydrocortisone tablets off the market and charge the NHS higher prices. This week’s edition also includes a Law360 analysis of a US ruling that Pfizer does not need to provide access to documents to a French non-profit about its coronavirus (COVID-19) vaccine development agreement with the French government in which Pfizer was granted indemnity. Also included, is news that the European Commission adopted the new legislation amending Regulation (EU) 712/2012 (Variations Regulation) to streamline the procedure for varying marketing authorisations of medicinal products as part of its pharmaceutical reform package and issued three factsheets about key areas of regulatory reform (ie access to medicines, preventing medicines shortages and rare disease innovation), the DHSC has announced new action to tackle ethnic and other biases in medical devices and news that the Commission adopted two implementing decisions on harmonised standards for medical devices, among other news stories.

This Q&A has been produced in partnership with Harry Spurr of IPOS Mediation. While the coronavirus (COVID-19) ‘lockdown’ has suffocated activity in many areas of normal life, those charged with responsibility for the authoring and publication of ‘guidance’ have been busier than ever. Not to be outdone, the mediation industry has been hard at work producing its own advice on remote mediation, and there is no shortage

This week's edition of Corporate Crime weekly highlights includes analysis of a recent High Court case which provided guidance on the correct interpretation of sanctions legislation and how the courts are likely to consider evidence of potential breaches, of a landmark decision for UK environmental protection in which a landowner will have money confiscated under POCA 2002 for felling crimes and of Boeing’s plea deal with the US Department of Justice. Also included is news of the SFO’s publication of details of Amec Foster Wheeler Energy Limited’s (AWFEL’s) compliance with a deferred prosecution agreement, of an update on the Insolvency Service’s ongoing work to tackle coronavirus (COVID-19) loan abuse and of a £3m fine for a recycling company for health and safety offences. All this, and more, in this week’s Corporate Crime highlights.

This week's edition of Corporate Crime weekly highlights includes analysis of the lack of focus on financial crime in the political parties’ manifestos and of how the Labour Party plans to create a new coronavirus (COVID-19) corruption tsar to recoup public money lost in fraud and failed contracts during the pandemic. Also included is news of the FCDO’s updated guidance on Russian sanctions as well as 50 new sanctions designations and specifications targeting Russia, of a construction company fined £2.345m after an employee drowned in a river and that the Post Office (Horizon System) Offences (Scotland) Act 2024 received Royal Assent thereby automatically exonerating wrongly convicted Scottish sub-postmasters. All this, and more, in this week’s Corporate Crime highlights.

ARCHIVED: This Practice Note has been archived and is not maintained. The Tier 1 (Entrepreneur) category was designed for people who wanted to join an existing UK business or establish their own business in the UK. The rules for this visa category are contained in paragraphs 245D–245DF of Part 6A of the Immigration Rules and paragraphs 35–53 of Appendix A of the Immigration Rules. The relevant rules relating to the English language and maintenance requirements are contained in paragraphs 1–15 of Appendix B and paragraphs 1A–3 of Appendix C respectively. The Home Office policy guidance can be viewed at Guidance on application for UK visa as Tier 1 (Entrepreneur). Who is eligible? This category closed to new applicants on 29 March 2019 although dependants can still apply to join a main applicant who has been granted leave as a Tier 1 (Entrepreneur). Extension applications for existing Tier 1 (Entrepreneur) migrants remained open until 5 April 2023 and applications for settlement (permanent residency also known as Indefinite

ARCHIVED: This Practice Note has been archived and is not maintained. This Practice Note is a summary of the key legal developments of relevance to personal injury and clinical negligence practitioners as of June 2020. For the most recent horizon scanner, reference should be made to PI and Clinical Negligence horizon scanning—overview. New special account rate The Ministry of Justice has announced the reduction of interest rates for Court Funds Office special and basic accounts from 1 June 2020. The special account rate has reduced from 0.5% to 0.1% and the basic account has reduced from 0.1% to 0.05%. The Lord Chancellor will further review the level of interest paid to clients should the Bank of England base rate rise in the future. See News Analysis: Changes to interest rates for Court Funds Office special and basic accounts and LNB News 01/06/2020 25. Coronavirus (COVID-19) To stay ahead of the fast-moving changes in the courts’ processes and procedures necessitated by the pandemic and for industry guidance on how

The death certification system in England and Wales was reformed with effect from 9 September 2024 to introduce changes recommended following various enquiries, including the third report of the Shipman Inquiry (relating to murders first investigated in the late 1990s). These include the implementation of the statutory medical examiner system as an additional safeguard. While Private Client practitioners will not usually be involved in the formalities regarding the medical certification of death, the reforms also impact the procedure for the legal registration of deaths in England and Wales. Requirement to register a death Registering the death is usually undertaken by a member of the deceased’s immediate family. The requirements for registering a death in England and Wales are governed by: • Births and Deaths Registration Act 1953 (BDRA 1953) • Registration Service Act 1953 (RSA 1953) • Coroners and Justice Act 2009 • Health and Care Act 2022, and • regulations made under each of those Acts Medical certificate of cause of death The registrar cannot register the death without a medical certificate. With

Key legislation, licences and guidance Source Details Legislation: The key legislation that underpins the Feed-in Tariff (FiT) scheme is the:Feed-in Tariffs Order 2012 (FiT 2012), SI 2012/2782, as amended by the:• Feed-in Tariffs and Contracts for Difference (Amendment) (EU Exit) Regulations 2018, SI 2018/1092 • Feed-in Tariffs (Closure, etc) Order 2018, SI 2018/1380 • Feed-in Tariffs (Amendment) (Coronavirus) Order 2020, SI 2020/375 • Feed-in Tariffs (Amendment) (Coronavirus) (No 2) Order 2020, SI 2020/957 • Feed-in Tariffs (Amendment) Order 2023, SI 2023/127 • Feed-in Tariffs (Amendment) Order 2026, SI 2026/2 Energy Act 2008 (EnA 2008), under which the FiT 2012 was made. Licence provisions: Along with the above legislation, the detailed mechanics of the FiT scheme are also implemented by the Standard Conditions of Electricity Supply Licences (SLCs), Con 33 and 34. Guidance: Ofgem provides the key guidance available in respect of the FiT scheme. Most notably this comprises:Feed-in Tariffs: Guidance for Renewable Installations (Ofgem Generator Guidance), andFeed-in Tariff: Guidance for licensed electricity suppliers (Ofgem Supplier Guidance)Feed-in Tariffs: Essential guide to closure of the

ARCHIVED: This Practice Note has been archived and is not maintained. CORONAVIRUS (COVID-19): Many arbitral organisations have responded to the coronavirus pandemic with practical guidance and/or changes to their usual procedures and ways of working. This Practice Note considers what a respondent should do upon receiving a Request for Arbitration under the 2017 International Chamber of Commerce (ICC) Rules of Arbitration (2017 ICC Rules). It also refers to the guidance in the ICC Note to Parties and Arbitral Tribunals on the Conduct of the Arbitration under the ICC Rules of Arbitration (ICC Note). References in this Practice Note to articles of and appendices to the ICC Arbitration Rules are to the 2017 ICC Rules unless otherwise indicated. The 2017 ICC Rules apply to any ICC arbitrations commenced on or after 1 March 2017 (unless the parties expressly agree that an earlier version of the ICC Rules will apply, which is unlikely). The 2017 ICC Rules include: • an expedited procedure which automatically applies where the arbitration agreement is entered into

ARCHIVED: This Practice Note has been archived and is not maintained. CORONAVIRUS (COVID-19): Many arbitral organisations have responded to the coronavirus pandemic with practical guidance and/or changes to their usual procedures and ways of working. This Practice Note considers the provisions regarding evidence in arbitration proceedings under the 2017 International Chamber of Commerce (ICC) Rules of Arbitration (2017 ICC Rules). It also refers to the guidance in the ICC Note to Parties and Arbitral Tribunals on the Conduct of the Arbitration under the ICC Rules of Arbitration (ICC Note). References in this Practice Note to articles of and appendices to the ICC Arbitration Rules are to the 2017 ICC Rules unless otherwise indicated. The 2017 ICC Rules apply to any ICC arbitrations commenced on or after 1 March 2017, unless the parties have agreed to submit to the rules in force on the date of their arbitration agreement (which is unlikely). The 2017 ICC Rules include: • an expedited procedure which automatically applies where the arbitration agreement is entered into after 1 March

The European Commission has authorised the mRNA vaccine ‘mResvia’ to protect adults over 60 against lower respiratory tract disease caused by respiratory syncytial virus (RSV) infection. This approval is the first vaccine to be authorised using mRNA technology to prevent a disease other than coronavirus (COVID-19). The European Medicines Agency authorisation comes ahead of the autumn/winter season when RSV infections tend to peak. National authorities will now decide on the vaccine’s use according to their vaccination plans.

The Insolvency Service has announced a 13-year directorship disqualification for Adam Ebrahim following fraudulent coronavirus bounce back loan (BBL) applications totalling £100,000. Ebrahim secured maximum-value loans for two non-trading companies by falsely claiming annual turnovers of £400,000 and £235,000. The companies, Chicken Grill Cottage Ltd and Presto Delivery Ltd, entered liquidation in June 2022 owing over £100,000. Ebrahim has been ordered to pay £9,555 in costs and is prohibited from company directorship until April 2038 without the court's permission.